Institute of Chemistry, Karl Franzens University Graz, Heinrichstrasse 28, 8010 Graz, Austria.
ChemMedChem. 2010 Oct 4;5(10):1760-9. doi: 10.1002/cmdc.201000252.
Dihydropyrimidine-based compounds belong to the first discovered inhibitors of the human mitotic kinesin Eg5. Although they are used by many research groups as model compounds for chemical genetics, considerably less emphasis has been placed on the improvement of this type of inhibitor, with the exception of two recent studies. Dihydropyrimidines can be divided into class I (analogues that bind in the S configuration) and class II type inhibitors, which bind in the R configuration. Herein we report the synthesis and optimization of novel class II type dihydropyrimidines using a combination of in vitro and docking techniques.
二氢嘧啶类化合物属于最早发现的人有丝分裂驱动蛋白 Eg5 的抑制剂。尽管许多研究小组将其用作化学遗传学的模型化合物，但除了最近的两项研究外，对这种抑制剂的改进关注较少。二氢嘧啶类化合物可分为 I 类（与 S 构型结合的类似物）和 II 类抑制剂，它们与 R 构型结合。本文报道了采用体外和对接技术相结合的方法，对新型 II 类二氢嘧啶进行了合成和优化。
